Sezgin, C. Et Al. 2025. Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol. Journal of Radioanalytical and Nuclear Chemistry .

Sezgin, C., UYGUR, E., PARLAK, Y., Karatay, B., Barutca, S., Dirican, A., ... SÖZEN, T. S.(2025). Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol. Journal of Radioanalytical and Nuclear Chemistry .

Sezgin, Ceren Et Al. "Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol," Journal of Radioanalytical and Nuclear Chemistry , 2025

Sezgin, Ceren Et Al. "Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol." Journal of Radioanalytical and Nuclear Chemistry , 2025

Sezgin, C. Et Al. (2025) . "Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol." Journal of Radioanalytical and Nuclear Chemistry .

@article{article, author={Ceren Sezgin Et Al. }, title={Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol}, journal={Journal of Radioanalytical and Nuclear Chemistry}, year=2025}